"The Four Seasons"
(of a Woman’s Sexuality)
February 22-25, 2007
Hilton in the Walt Disney World Resort
Meeting Program Schedule

Program is subject to change

Continental Breakfast and Registration

Welcome and Introduction
Sharon Parish, MD

Identification of Sexual Health Problems:
History, questionnaires, psychologic interview & physical exam
Sharon Parish, MD

Testing procedures (hormonal, vascular, neurologic)
Irwin Goldstein, MD

Q & A

Education:
Relevant anatomy, physiology & pathophysiology
Sharon Parish, MD

Expectations of patient & partner
Stan Althof, PhD

Q & A

Modification of Reversible Causes:
Sex therapy strategies
Stan Althof, PhD

Physical therapy, diet, exercise, changing medications, lubricants
Sharon Parish, MD

Q & A

Refreshment Break

First Line Therapies:
Hormonal Treatment
Irwin Goldstein, MD

Non-hormonal treatment
(dopamine agonists, PDE 5 inhibtors)
Sharon Parish, MD

Q & A

Second Line Therapies:
Surgery
Irwin Goldstein, MD

CASE STUDIES
33 y.o. woman with sexual dysfunction following sexual abuse
Stan Althof, PhD

40 y.o. woman on OCP’s with vulvar vestibulitis
Sharon Parish, MD

55 y.o. post-menopausal woman can no longer achieve orgasm
Irwin Goldstein, MD

Conclusion
Irwin Goldstein, MD

Box Lunch

Opening Ceremony – Introductions

State-of-the-Art Lecture #1 (Presidential Lecture)
Anita Clayton, MD

Selected Paper Session #1

Concurrent Instructional Course #1 View Course Outline
Practical aspects of the management of pre- and post-menopausal women with sexual pain disorders
Andrew T. Goldstein, MD
Caroline Pukall, PhD

Break

Discussants:
Peggy Cohen-Kettenis, PhD: Typical and atypical gender development
Dennis Fortenberry, PhD: Sexual satisfaction and sexual self-concept in adolescent women
Meredith Chivers, PhD: Sexual psychophysiology of women's sexual orientation

Industry Sponsored Symposium
The Mind and Sex: Role of CNS Acting Agents in FSD

Welcome Reception

FRIDAY, FEBRUARY 23, 2007

Industry Sponsored Symposium
Palm III & IV
Drug Development for FSD (Libifem); Efficacy studies both physiological and subjective and the Influence of Inhibition and excitation mechanisms

Speakers:
Prof.Dr. W. Everaerd (chair)
Dr. A. Tuiten
J. Bloemers (MSc)
F.van der Made (MD)
Prof. Dr. B. Olivier

Discussants:
Salvatore Caruso, MD: Premenopausal consequences of oral contraceptives
Craig H. Kinsley, PhD: Motherhood produces long-lasting neuronal and behavioral modifications in the female
Alia Offman, PhD: Compatibility and communication: Keys to sexual functioning in intimate relationships

Break

Concurrent Instructional Course #2 View Course Outline
Practical aspects of the management of FSD as a consequence of depression and/or medications that treat depression
Anita Clayton, MD
Marty Miner, MD

Lunch

State-of-the-Art Lecture #2
Where in the brain is female sexual response?
Barry Komisaruk, PhD
Beverly Whipple, PhD

Discussants:
Lorraine Dennerstein, MBSS, PhD: Reproductive aging and sexual function
Sandra Leiblum, PhD: Genital arousal in women: Normal, problematical, pathological
Esther Perel, PhD: When three threatens two: sex and parenthood

Poster Session (wine & cheese)

SATURDAY, FEBRUARY 24, 2007

The Journal Of Sexual Medicine Breakfast Debate
"The ruling of the EMEA approving testosterone for some women with FSD will have significant impact for women with FSD worldwide."
Moderator:
Irwin Goldstein, MD
Pro:
James A. Simon, MD
Stephanie Buehler, PhD
Con:
Sharon Parish, MD
Jean Fourcroy, MD

Discussants:
James A. Simon, MD: Androgen co-therapy of the menopausal woman
Barbara Sherwin, MD: Does estrogen protect against cognitive aging in the winter of women's lives?
Istvan Merchenthaler, MD, DSc: The Good, the Bad, and the Ugly: Divergent aspects of gonadal steroids on models of neurologic disease

Break

Roundtable: What is sexual desire and how do we know?
Moderator:
Sheryl Kingsberg, PhD

Discussants:
Rosemary Basson, MD, FRCP
Stephen B. Levine, MD

Lunch

Concurrent Instructional Course #3 View Course Outline
Practical aspects of the management of FSD in women with breast cancer
Michael Krychman, MD

Break

State-of-the-Art Lecture #3
The major role of extragonadal sex steroid formation (intracrinology) in women, especially after menopause
Fernand Labrie, MD

Clinical Cases
Discussants:
Ellen Laan, PhD
Rik van Lunsen, MD
Marie-Andree Lahaie, PhD

Annual Business Meeting

Banquet

Board of Directors Meeting

Concurrent Instructional Course #4 View Course Outline
Practical aspects in the management of FSD by hormone therapy (androgens, estrogens, progestins)
James A. Simon, MD
Claudia Panzer, MD